Neonatal vitamin K refusal and nonimmunization

Vanita Sahni1, Florence Y Lai1, Shannon E MacDonald2

  • 1Alberta Health Surveillance and Assessment, Edmonton, Alberta, Canada;

Pediatrics
|August 20, 2014
PubMed

Insights

Parents who refuse vitamin K for newborns are significantly more likely to refuse childhood immunizations. This study identifies characteristics of these parents to improve intervention strategies for both vitamin K and vaccine uptake.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Neonatal Vitamin K prophylaxis prevents vitamin K deficiency bleeding.
  • Parental refusal of vitamin K prompted investigation into its prevalence and association with subsequent immunization refusal.

Purpose of the Study:

  • To determine the prevalence and characteristics of parents who refuse vitamin K for their infants.
  • To assess the association between vitamin K refusal and subsequent refusal of childhood immunizations.

Main Methods:

  • Retrospective population-based cohort study using linked administrative health data (Alberta, 2006-2012).
  • Poisson regression used to identify risk factors for vitamin K refusal.
  • Relative risk assessed the association between vitamin K refusal and non-immunization.

Main Results:

  • 0.3% of 282,378 infants declined vitamin K prophylaxis.
  • Vitamin K refusal was associated with midwife-assisted delivery, planned home birth, or birth center delivery.
  • Vitamin K refusal increased the relative risk of no childhood vaccines at 15 months by 14.6-fold.

Conclusions:

  • First population-based study characterizing parents who refuse vitamin K and whose children remain unimmunized.
  • Findings allow earlier identification of high-risk parents.
  • Opportunities exist to implement strategies for increasing uptake of vitamin K and childhood immunizations.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
544
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
399